FUJIFILM Diosynth Biotechnologies will invest $1.2 billion to expand its biopharmaceutical manufacturing facility in Holly Springs, North Carolina, creating 680 new jobs in Wake County. Initial investments of the FUJIFILM’s Holly Springs operation included $2 billion in 2021. The company claims it’s the largest end-to-end biopharmaceutical manufacturing facility in North America. Holly

FUJIFILM Diosynth Biotechnologies’ expansion includes an additional large-scale monoclonal antibody Drug Substance manufacturing capacity that will support the company’s growing biologics CDMO business. The project will also include two additional drug substance manufacturing buildings, a shared headblock building with administrative space, as well as expansions of utilities, lab, and warehouse buildings currently under construction.

The average salary for new positions at FUJIFILM Diosynth Biotechnologies will be $109,923, which is nearly 50% higher than Wake County’s average wage of $74,866.

The Japanese contract drug manufacturer will receive $69.2 million in incentives from the state as well as Wake County and Holly Springs if it meets hiring and investment targets.